Search Results - Ann C Collier

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection. by Joanne D Stekler, Giovanina M Ellis, Jacquelyn Carlsson, Braiden Eilers, Sarah Holte, Janine Maenza, Claire E Stevens, Ann C Collier, Lisa M Frenkel

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  2. 2

    U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment by Susan M. Graham, Douglas Barthold, Brett Hauber, Aaron T. Brah, Enrique Saldarriaga, Ann C. Collier, Rodney J. Y. Ho, the Emory PREFER Team, Vincent C. Marconi, Jane M. Simoni

    Published in Journal of the International AIDS Society (2023-07-01)
    Get full text
    Article


  3. 3

    Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanc... by Robert A. Salata, Beatriz Grinsztejn, Justin Ritz, Ann C. Collier, Evelyn Hogg, Robert Gross, Catherine Godfrey, Nagalingeswaran Kumarasamy, Cecilia Kanyama, John W. Mellors, Carole L. Wallis, Michael D. Hughes, the ACTG A5288 Study Team

    Published in AIDS Research and Therapy (2023-01-01)
    Get full text
    Article


  4. 4

    Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation by Jaimy Joy, Ana Gervassi, Lennie Chen, Brent Kirshenbaum, Sheila Styrchak, Daisy Ko, Sherry McLaughlin, Danica Shao, Ewelina Kosmider, Paul T. Edlefsen, Janine Maenza, Ann C. Collier, James I. Mullins, Helen Horton, Lisa M. Frenkel

    Published in The Journal of Clinical Investigation (2024-07-01)
    Get full text
    Article


  5. 5

    Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection. by Eric S Rosenberg, Barney S Graham, Ellen S Chan, Ronald J Bosch, Vicki Stocker, Janine Maenza, Martin Markowitz, Susan Little, Paul E Sax, Ann C Collier, Gary Nabel, Suzanne Saindon, Theresa Flynn, Daniel Kuritzkes, Dan H Barouch, AIDS Clinical Trials Group A5187 Team

    Published in PLoS ONE (2010-05-01)
    Get full text
    Article


  6. 6

    Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. by Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, Christina M Lalama, Joshua C Cyktor, Bernard J Macatangay, Charles R Rinaldo, Sharon A Riddler, Evelyn Hogg, Catherine Godfrey, Ann C Collier, Joseph J Eron, John W Mellors, ACTG A5321 Team

    Published in PLoS Pathogens (2017-04-01)
    Get full text
    Article


  7. 7

    Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection. by Tiffany Hensley-McBain, Michael C Wu, Jennifer A Manuzak, Ryan K Cheu, Andrew Gustin, Connor B Driscoll, Alexander S Zevin, Charlene J Miller, Ernesto Coronado, Elise Smith, Jean Chang, Michael Gale, Ma Somsouk, Adam D Burgener, Peter W Hunt, Thomas J Hope, Ann C Collier, Nichole R Klatt

    Published in PLoS Pathogens (2019-04-01)
    Get full text
    Article


  8. 8

    Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial by Robert Gross, MD MSCE, Justin Ritz, MS, Michael D Hughes, ProfPhD, Robert Salata, ProfMD, Peter Mugyenyi, ProfFRCPE, Evelyn Hogg, BA, Linda Wieclaw, BA, Catherine Godfrey, MD, Carole L Wallis, PhD, John W Mellors, ProfMD, Victor O Mudhune, MPH, Sharlaa Badal-Faesen, MBBCh, Beatriz Grinsztejn, ProfMD, Ann C Collier, ProfMD

    Published in The Lancet: Digital Health (2019-05-01)
    Get full text
    Article


Search Tools: